These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 15070707)
21. Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia-like phenotype, and no chromosome fragility. Keupp K; Hampp S; Hübbel A; Maringa M; Kostezka S; Rhiem K; Waha A; Wappenschmidt B; Pujol R; Surrallés J; Schmutzler RK; Wiesmüller L; Hahnen E Mol Genet Genomic Med; 2019 Sep; 7(9):e863. PubMed ID: 31347298 [TBL] [Abstract][Full Text] [Related]
22. Fanconi anemia and leukemia: tracking the genes. Auerbach AD Leukemia; 1992; 6 Suppl 1():1-4. PubMed ID: 1548931 [TBL] [Abstract][Full Text] [Related]
23. Inherited FANCD1/BRCA2 exon 7 splice mutations associated with acute myeloid leukaemia in Fanconi anaemia D1 are not found in sporadic childhood leukaemia. Barber LM; Barlow RA; Meyer S; White DJ; Will AM; Eden TO; Taylor GM Br J Haematol; 2005 Sep; 130(5):796-7. PubMed ID: 16115142 [No Abstract] [Full Text] [Related]
24. Screening Fanconi anemia lymphoid cell lines of non-A, C, D2, E, F, G subtypes for defects in BRCA2/FANCD1. Popp H; Kalb R; Fischer A; Lobitz S; Kokemohr I; Hanenberg H; Schindler D Cytogenet Genome Res; 2003; 103(1-2):54-7. PubMed ID: 15004464 [TBL] [Abstract][Full Text] [Related]
25. Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype. Sawyer SL; Tian L; Kähkönen M; Schwartzentruber J; Kircher M; ; ; Majewski J; Dyment DA; Innes AM; Boycott KM; Moreau LA; Moilanen JS; Greenberg RA Cancer Discov; 2015 Feb; 5(2):135-42. PubMed ID: 25472942 [TBL] [Abstract][Full Text] [Related]
26. Fanconi anemia gene mutations are not involved in sporadic Wilms tumor. Adank MA; Segers H; van Mil SE; van Helsdingen YM; Ameziane N; van den Ouweland AM; Wagner A; Meijers-Heijboer H; Kool M; de Kraker J; Waisfisz Q; van den Heuvel-Eibrink MM Pediatr Blood Cancer; 2010 Oct; 55(4):742-4. PubMed ID: 20589654 [TBL] [Abstract][Full Text] [Related]
27. Fanconi anemia and solid malignancies in childhood: a national retrospective study. Malric A; Defachelles AS; Leblanc T; Lescoeur B; Lacour B; Peuchmaur M; Maurage CA; Pierron G; Guillemot D; d'Enghien CD; Soulier J; Stoppa-Lyonnet D; Bourdeaut F Pediatr Blood Cancer; 2015 Mar; 62(3):463-70. PubMed ID: 25381700 [TBL] [Abstract][Full Text] [Related]
28. Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children. Svojgr K; Sumerauer D; Puchmajerova A; Vicha A; Hrusak O; Michalova K; Malis J; Smisek P; Kyncl M; Novotna D; Machackova E; Jencik J; Pycha K; Vaculik M; Kodet R; Stary J Eur J Med Genet; 2016 Mar; 59(3):152-7. PubMed ID: 26657402 [TBL] [Abstract][Full Text] [Related]
29. Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility. Lakhi NA; Mizejewski GJ Fetal Pediatr Pathol; 2017 Feb; 36(1):49-61. PubMed ID: 27690720 [TBL] [Abstract][Full Text] [Related]
31. A homozygous nonsense mutation early in exon 5 of BRCA2 is associated with very severe Fanconi anemia. Radulovic I; Kuechler A; Schündeln MM; Paulussen M; von Neuhoff N; Reinhardt D; Hanenberg H Eur J Med Genet; 2021 Aug; 64(8):104260. PubMed ID: 34118472 [TBL] [Abstract][Full Text] [Related]
32. Susceptibility pathways in Fanconi's anemia and breast cancer. D'Andrea AD N Engl J Med; 2010 May; 362(20):1909-19. PubMed ID: 20484397 [TBL] [Abstract][Full Text] [Related]
33. A cross-linker-sensitive myeloid leukemia cell line from a 2-year-old boy with severe Fanconi anemia and biallelic FANCD1/BRCA2 mutations. Meyer S; Fergusson WD; Oostra AB; Medhurst AL; Waisfisz Q; de Winter JP; Chen F; Carr TF; Clayton-Smith J; Clancy T; Green M; Barber L; Eden OB; Will AM; Joenje H; Taylor GM Genes Chromosomes Cancer; 2005 Apr; 42(4):404-15. PubMed ID: 15645491 [TBL] [Abstract][Full Text] [Related]
34. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Kutler DI; Singh B; Satagopan J; Batish SD; Berwick M; Giampietro PF; Hanenberg H; Auerbach AD Blood; 2003 Feb; 101(4):1249-56. PubMed ID: 12393516 [TBL] [Abstract][Full Text] [Related]
35. Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis. Alter BP; Best AF Breast Cancer Res Treat; 2020 Jul; 182(2):465-476. PubMed ID: 32488392 [TBL] [Abstract][Full Text] [Related]
37. Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry. Rosenberg PS; Alter BP; Ebell W Haematologica; 2008 Apr; 93(4):511-7. PubMed ID: 18322251 [TBL] [Abstract][Full Text] [Related]
38. The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer. Esteban-Jurado C; Franch-Expósito S; Muñoz J; Ocaña T; Carballal S; López-Cerón M; Cuatrecasas M; Vila-Casadesús M; Lozano JJ; Serra E; Beltran S; Brea-Fernández A; Ruiz-Ponte C; Castells A; Bujanda L; Garre P; Caldés T; Cubiella J; Balaguer F; Castellví-Bel S Eur J Hum Genet; 2016 Oct; 24(10):1501-5. PubMed ID: 27165003 [TBL] [Abstract][Full Text] [Related]
39. The Fanconi road to cancer. D'Andrea AD Genes Dev; 2003 Aug; 17(16):1933-6. PubMed ID: 12893780 [No Abstract] [Full Text] [Related]